Comprehensive transcriptome, miRNA and kinome profiling identifies new treatment options for personalized lung cancer therapy

Documenti analoghi

• A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction‐associated steatotic liver disease
  di: Shifang Tang, et al.
  Pubblicazione: (2025)
• Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression
  di: Ning Wu, et al.
  Pubblicazione: (2025)
• Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph‐node invasion
  di: Matias A. Bustos, et al.
  Pubblicazione: (2025)
• Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
  di: Mengrui Liu, et al.
  Pubblicazione: (2025)
• Evaluating miRNA Sequencing and Integrative Proteomics for Identifying Plasma miRNAs as Potential Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
  di: Mai Mehanna, et al.
  Pubblicazione: (2025)